ANI Pharmaceuticals reported $621.56M in Debt for its fiscal quarter ending in June of 2025.


Debt Change Date
AbbVie USD 69.89B 2.74B Mar/2025
ANI Pharmaceuticals USD 621.56M 1.26M Jun/2025
Aurora Cannabis CAD 101.63M 648K Jun/2025
Canopy Growth CAD 327.8M 161.87M Jun/2025
Eli Lilly USD 39.9B 1.39B Jun/2025
Hikma Pharmaceutical USD 1.31B 30M Dec/2024
Knight Therapeutics CAD 58.22M 109K Sep/2024
Novartis USD 32.64B 1.38B Jun/2025
Perrigo USD 3.65B 24.4M Jun/2025
Sun Pharmaceuticals INR 23.62B 2.1B Mar/2025
Teva Pharmaceutical Industries USD 17.52B 872M Jun/2025